Home/Pipeline/Accel-Heal Solo Commercial Expansion

Accel-Heal Solo Commercial Expansion

Hard-to-heal wounds (Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers)

CommercialActive

Key Facts

Indication
Hard-to-heal wounds (Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers)
Phase
Commercial
Status
Active
Company

About Accel-Heal Technologies

Accel-Heal Technologies is a private, commercial-stage company offering a clinically validated, wearable medical device for chronic wound care. Its core technology leverages microcurrent electrical stimulation (EST), a modality backed by substantial evidence including meta-analyses and RCTs, to reactivate stalled healing processes and reduce pain. The company's strategy centers on making this traditionally complex therapy simple and cost-effective for use across care settings, including patient self-management at home. Recent milestones include securing tenders (e.g., Emirates Health Services) and expanding distribution into new regions like the Nordics.

View full company profile

Therapeutic Areas